Best Treatment Modality of Frozen Shoulder

Shoulder Adhesive Capsulitis Clinical Trial

Official title:

Shoulder Adhesive Capsulitis ; Comparison Between Three Theraputic Approaches

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04897308
• Other study ID #: Soh-Med-21-05-04
• Status: Completed
• Phase: N/A
• Start date: May 1, 2021
• Est. completion date: April 1, 2022

Study information

• Verified date: April 2022
• Source: Sohag University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will compare between the effect of three treatment modalities of shoulder adhesive capsulitis to hilight the best technique to improve pain and range of motion outcome measures .

Recruitment information / eligibility

• Status: Completed
• Enrollment: 54
• Est. completion date: April 1, 2022
• Est. primary completion date: April 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• gross limitation of passive shoulder movement

• pain interfering with daily activities

• painful restiction of active and passive movement of shoulder

Exclusion Criteria:

• presence of degenerative pathology

• fracture

• contraindication to steroid injection

• deformity affecting upper limb

• history of previous shoulder injection in the past 4 weeks

Related Conditions & MeSH terms

• Bursitis
• Shoulder Adhesive Capsulitis

Intervention

Procedure:
• Local injection of shoulder joint
Under ultrasound guidance , local shoulder joint injection will be done

Locations

Country	Name	City	State
Egypt	Sohag faculty	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement in range of motion of shoulder joint	Improvement will be measured by measuring active and passive range of motion	12 weeks efter intervention
Primary	Improvement in pain	Improvement will be measured by VAS ( visual auditory assessment )	12 weeks after intervention